BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,045.53
      0.78%
      US Tech 100
      20,617.20
      1.12%
      Dow Jones
      44,799.19
      -0.25%
      Brent Oil
      71.635
      -0.61%
      Bitcoin
      95,691.67
      -1.61%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV

      6. Ceapro Inc (CZO) Quote

      Ceapro Inc

      Ceapro Inc (CZO)

      TSXV
      0.225
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.225
      Bid
      0.16
      Ask
      0.30
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      17.616M
      Previous Close
      0.225
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      78,293,000
      Dividend Yield
      -
      PE Ratio
      -3.65
      Earnings Per Share (EPS)
      -0.06
      Revenue
      9.63M
      Net Profit
      -4.71M

      About Ceapro Inc

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Medicinal Chems,botanicl Pds
      Headquarters
      Edmonton, Alberta, Can
      Founded
      -
      Ceapro Inc is listed in the Medicinal Chems,botanicl Pds sector of the TSX Venture Exchange with ticker CZO. The last closing price for Ceapro was $0.23. Over the last year, Ceapro shares have traded in a share price range of $ 0.00 to $ 0.00.

      Ceapro currently has 78,293,000 shares outstanding. The market capitalization of Ceapro is $17.62 million. Ceapro has a price to earnings ratio (PE ratio) of -3.65.

      Ask ADVFN Intelligence (AI)

      CZO Latest News

      More News

      Aeterna Zentaris and Ceapro Complete Merger Transaction

      TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF...

      June 03 2024
      GlobeNewswire Inc.

      Aeterna Zentaris and Ceapro Complete Merger Transaction

      TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two...

      June 03 2024
      GlobeNewswire Inc.

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZO

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZO Canada NewsWire VANCOUVER, BC, le 3 juin 2024 VANCOUVER, BC, le 3 juin 2024 /CNW/...

      June 03 2024
      PR Newswire (Canada)

      Canadian Investment Regulatory Organization Trading Halt - CZO

      Canadian Investment Regulatory Organization Trading Halt - CZO Canada NewsWire VANCOUVER, BC, June 3, 2024 VANCOUVER, BC, June 3, 2024 /CNW/ - The following issues have been halted by...

      June 03 2024
      PR Newswire (Canada)

      Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

      – Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pilot scale...

      May 29 2024
      GlobeNewswire Inc.

      Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

      – 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the...

      April 29 2024
      GlobeNewswire Inc.

      Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

      TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

      March 28 2024
      GlobeNewswire Inc.

      Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

      TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased...

      March 12 2024
      GlobeNewswire Inc.

      Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

      TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

      March 12 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ETUE2gold Inc
      $ 0.01
      (100.00%)
      		561.28k
      DMDataMetrex AI Limited
      $ 0.01
      (100.00%)
      		16.19k
      FONC.PFlorence One Capital Inc
      $ 0.07
      (75.00%)
      		11k
      NZNew Zealand Energy Corp
      $ 1.13
      (73.85%)
      		78.62k
      USCUUS Copper Corp
      $ 0.05
      (66.67%)
      		43.25k
      PLRBPluribus Technologies Corp
      $ 0.04
      (-55.56%)
      		6k
      TVITVI Pacific Inc
      $ 0.005
      (-50.00%)
      		7.51k
      MVYMoovly Media Inc
      $ 0.005
      (-50.00%)
      		1.08M
      AQSAequus Pharmaceuticals Inc
      $ 0.005
      (-50.00%)
      		3k
      MGIMagnum Goldcorp Inc
      $ 0.025
      (-50.00%)
      		12k
      NSENew Stratus Energy Inc
      $ 0.485
      (-32.64%)
      		1.56M
      CSTRCryptoStar Corp
      $ 0.03
      (0.00%)
      		1.5M
      CPERCoppercorp Resources Inc
      $ 0.25
      (16.28%)
      		1.4M
      MATEBlockmate Ventures Inc
      $ 0.11
      (0.00%)
      		1.36M
      MVYMoovly Media Inc
      $ 0.005
      (-50.00%)
      		1.08M

      CZO Discussion

      View Posts
      stocker11 stocker11 8 years ago
      Have they started testing the product for Cholesterol reduction.
      👍️0
      stocker11 stocker11 8 years ago
      Looking to buy in soon - should I wait until for the K is filed at the end of the month?
      👍️0
      Michon Michon 8 years ago
      What make's this stock special?
      👍️0
      notofthisworld notofthisworld 8 years ago
      This article underlines the potential of this company.

      http://www.theglobeandmail.com/globe-investor/investment-ideas/why-this-canadian-biotech-firms-cheap-stock-is-a-hidden-gem/article33325243/
      👍️0
      notofthisworld notofthisworld 8 years ago
      This won't be under 2$ for much longer.
      👍️0

      Your Recent History

      TSXV
      CZO
      Ceapro
      USOTC
      CCASY
      Carlos Casado (GM)
      BOV
      TCSA3F
      TECNISA ON
      Delayed Upgrade Clock